Clinical Trial Update: Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

View source ↗

Summary

Update on a clinical trial evaluating the central vein sign as a diagnostic biomarker for multiple sclerosis; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: The Cleveland Clinic | Conditions: Multiple Sclerosis | Status: ACTIVE_NOT_RECRUITING